|
FAM126A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.215400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.892200E-01 |
| Normal-vs-Stage2 |
4.416400E-01 |
| Normal-vs-Stage3 |
1.322620E-01 |
| Normal-vs-Stage4 |
7.339000E-01 |
| Stage1-vs-Stage2 |
2.727600E-01 |
| Stage1-vs-Stage3 |
8.484100E-02 |
| Stage1-vs-Stage4 |
5.527800E-01 |
| Stage2-vs-Stage3 |
5.268000E-01 |
| Stage2-vs-Stage4 |
8.611800E-01 |
| Stage3-vs-Stage4 |
5.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.339000E-01 |
| Normal-vs-AfricanAmerican |
5.572400E-01 |
| Normal-vs-Asian |
1.832570E-01 |
| Caucasian-vs-AfricanAmerican |
5.799600E-01 |
| Caucasian-vs-Asian |
1.859180E-01 |
| AfricanAmerican-vs-Asian |
4.414100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.129400E-01 |
| Normal-vs-Female |
7.356200E-03 |
| Male-vs-Female |
1.002060E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.991400E-01 |
| Normal-vs-Extreme_Weight |
4.141800E-01 |
| Normal-vs-Obese |
1.897820E-01 |
| Normal-vs-Extreme_Obese |
1.474000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.344600E-01 |
| Normal_Weight-vs-Obese |
1.563780E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.838600E-01 |
| Extreme_Weight-vs-Obese |
7.325500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.652200E-01 |
| Obese-vs-Extreme_Obese |
6.315700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.671530E-02 |
| Normal-vs-Age(41-60Yrs) |
1.597830E-01 |
| Normal-vs-Age(61-80Yrs) |
1.435220E-01 |
| Normal-vs-Age(81-100Yrs) |
3.878200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.212100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.038900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.543500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.579000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.838960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.753400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.824200E-01 |
| Normal-VS-Type2 PRCC |
1.888440E-01 |
| Normal-VS-KIRP CIMP |
2.870000E-02 |
| Normal-VS-Unclassified PRCC |
7.748100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.173500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.044200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.366400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.925940E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.848180E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.694300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.080200E-01 |
| Normal-vs-N1 |
6.444000E-02 |
| Normal-vs-N2 |
3.488200E-01 |
| N0-vs-N1 |
4.309800E-02 |
| N0-vs-N2 |
1.976370E-01 |
| N1-vs-N2 |
7.699600E-01 |
|
|
